Literature DB >> 16619213

Confirmation of the origin of NISCH syndrome.

L Feldmeyer1, M Huber, F Fellmann, J S Beckmann, E Frenk, D Hohl.   

Abstract

Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome, a rare autosomal recessive ichthyosis syndrome characterized by scalp hypotrichosis, scarring alopecia, ichthyosis, and sclerosing cholangitis, was described for the first time in 2002. It is caused by a mutation in the gene coding for the tight junction protein claudin-1. Only four patients carrying the same mutation of the CLDN1 gene have been described until now. We report a patient presenting with the clinical characteristics of NISCH syndrome and carrying a novel mutation in the CLDN1 gene. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619213     DOI: 10.1002/humu.20333

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.

Authors:  Akiharu Kubo; Keisuke Nagao; Masayuki Amagai
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 2.  Scaffolding proteins in the development and maintenance of the epidermal permeability barrier.

Authors:  Melissa Crawford; Lina Dagnino
Journal:  Tissue Barriers       Date:  2017-06-30

Review 3.  Tight junctions in skin inflammation.

Authors:  Katja Bäsler; Johanna M Brandner
Journal:  Pflugers Arch       Date:  2016-11-16       Impact factor: 3.657

4.  Gene-Targeted Next-Generation Sequencing Identifies a Novel CLDN1 Mutation in a Consanguineous Family With NISCH Syndrome.

Authors:  Leila Youssefian; Hassan Vahidnezhad; Amir Hossein Saeidian; Soheila Sotoudeh; Sirous Zeinali; Jouni Uitto
Journal:  Am J Gastroenterol       Date:  2017-02       Impact factor: 10.864

Review 5.  Junctional proteins of the blood-brain barrier: New insights into function and dysfunction.

Authors:  Svetlana M Stamatovic; Allison M Johnson; Richard F Keep; Anuska V Andjelkovic
Journal:  Tissue Barriers       Date:  2016-02-26

6.  Tight junction defects in patients with atopic dermatitis.

Authors:  Anna De Benedetto; Nicholas M Rafaels; Laura Y McGirt; Andrei I Ivanov; Steve N Georas; Chris Cheadle; Alan E Berger; Kunzhong Zhang; Sadasivan Vidyasagar; Takeshi Yoshida; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon M Hanifin; Richard L Gallo; Natalija Novak; Stephan Weidinger; Terri H Beaty; Donald Y M Leung; Kathleen C Barnes; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2010-12-15       Impact factor: 10.793

Review 7.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

8.  Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry.

Authors:  Vincent Bekker; Thomas R O'Brien; Stephen Chanock
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

Review 9.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

10.  Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection.

Authors:  V Bekker; S J Chanock; M Yeager; A A Hutchinson; T von Hahn; S Chen; N Xiao; M Dotrang; M Brown; M P Busch; B R Edlin; C M Rice; T R O'Brien
Journal:  J Viral Hepat       Date:  2009-08-07       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.